| ST002948 Multi-omics Approach Reveals a Specific Profile in Severe Asthmatic Patients Treated with Mepolizumab or Omalizumab | ||||
| Limit by pathway class: | ||||
| ST002948 Multi-omics Approach Reveals a Specific Profile in Severe Asthmatic Patients Treated with Mepolizumab or Omalizumab | ||||
| Limit by pathway class: | ||||
|